NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/22/2026
Back to search
Official data from USPTO
BIOMARIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
02/10/2026
Trademark type
Word
Nice classes
1, 5
Filing date
04/10/2001
Registration date
10/18/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/22/2026
Last transaction
02/10/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/30/2004
First use in commerce
11/30/2004
Drawing code
1
Owner type
03
Owner location
Novato, CA, US
Examiner
DELANEY, ZHALEH SYBIL
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Biomarin Pharmaceutical Inc.
Representatives
Gregory J. Chinlund MARSHALL, GERSTEIN & BORUN LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
assaysscreening kitsdevicesequipment for scientific analysis and diagnosis of disorders and physiological processes; assaysscreening kitsdevicesequipment for measurement of disease markers for scientific purposes
Class 5
pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceuticals for treatment of inflammationinfectious diseases and cardiovascular diseases; assaysscreening kitsdevicesequipment for medical analysis and diagnosis of disorders and physiological processes; assaysscreening kitsdevicesequipment for measurement of disease markers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; fungal lytic enzymes for the treatment of fungal infections; pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders; proteins and enzymes for the productionpurification and isolation of biologics for use in the treatment of medical conditions; biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions
Publications
History of USPTO decisions and trademark events.
50 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
01/22/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/22/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/22/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
10/16/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/18/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/21/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/21/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/21/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
10/16/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/16/2011
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/16/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/16/2011
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/17/2011
E815
TEAS SECTION 8 & 15 RECEIVED
10/17/2011
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/07/2011
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/07/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
10/18/2005
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/06/2005
ALIE
ASSIGNED TO LIE
09/02/2005
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/26/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
08/26/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/17/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/17/2005
CNFR
FINAL REFUSAL MAILED
07/01/2005
CNFR
SU - FINAL REFUSAL - WRITTEN
07/01/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/29/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2005
PAPER RECEIVED
06/15/2005
CNRT
NON-FINAL ACTION MAILED
04/18/2005
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/18/2005
PAPER RECEIVED
03/15/2005
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/11/2005
IUAF
USE AMENDMENT FILED
03/11/2005
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/14/2004
OP.T
OPPOSITION TERMINATED NO. 999999
06/10/2004
OP.D
OPPOSITION DISMISSED NO. 999999
06/10/2004
PAPER RECEIVED
09/12/2003
OP.I
OPPOSITION INSTITUTED NO. 999999
09/06/2003
PUBO
PUBLISHED FOR OPPOSITION
04/01/2003
NPUB
NOTICE OF PUBLICATION
03/12/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2003
CNEA
EXAMINERS AMENDMENT MAILED
01/16/2003
CNRT
NON-FINAL ACTION MAILED
11/26/2002
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/19/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/20/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2002
CNRT
NON-FINAL ACTION MAILED
11/01/2001
DOCK
ASSIGNED TO EXAMINER
10/25/2001
DOCK
ASSIGNED TO EXAMINER
10/24/2001
Continuous trademark protection
Get notified about every new filing that threatens BIOMARIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.